These drugs work by mimicking a hormone in your body (GLP-1) that helps regulate blood sugar and hunger signals
[1] [2] Some patients have reported experiencing sore throat symptoms whilst taking Saxenda, though these reports should be considered alongside the background rate of throat symptoms in the general population
The combination of gastrointestinal fluid losses and a regimen that already limits renal compensation is the specific scenario to be alert to
"We are encouraged by the results which highlight the powerful effect of retatrutide, a first-in-class triple agonist, on body weight, pain and physical function
Month 2 is where mental preparation matters most
On the other hand, the adverse events of GLP-1 drugs have been extensively characterized from large randomized trials with placebo controls and, in the United States, from reports derived from 12% of Americans who are currently taking these drugs